SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-288073
Filing Date
2020-11-06
Accepted
2020-11-06 17:05:32
Documents
14
Period of Report
2020-11-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d68940d8k.htm   iXBRL 8-K 29794
2 EX-5.1 d68940dex51.htm EX-5.1 15353
6 GRAPHIC g68940paulhastings.jpg GRAPHIC 2341
  Complete submission text file 0001193125-20-288073.txt   177041

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sppi-20201106.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sppi-20201106_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sppi-20201106_pre.xml EX-101.PRE 11403
7 EXTRACTED XBRL INSTANCE DOCUMENT d68940d8k_htm.xml XML 3404
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filer) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35006 | Film No.: 201295227
SIC: 2834 Pharmaceutical Preparations